Case study

Bridging company constraints and patient reality

Alcediag needed more than generic patient feedback. The team needed to understand how people affected by bipolarity, depression, and their loved ones would interpret a precision psychiatry blood test, what would build trust, and what language could make the offer feel respectful rather than frightening.

A patient-led insight and go-to-market project for a French precision psychiatry diagnostics company.

Clément Baissat with the Alcediag team
HopeStage with the Alcediag team
Alcediag
Partner

Alcediag

French diagnostics company specializing in precision psychiatry.

Product context

myEDIT-B

A blood test designed to help differentiate depression from bipolarity.

HopeStage role

Patient insight and adoption strategy

Qualitative research, personas, patient language, positioning, and go-to-market recommendations.

The challenge

A diagnostic innovation still has to be understood by real people.

For a company building a diagnostic test in mental health, the science is only one part of adoption. People need to understand what the test means, what it does not mean, how it relates to their story, and whether the communication feels safe enough to trust.

Patient trust

The message had to acknowledge the sensitivity of diagnosis, identity, stigma, and uncertainty.

Audience segmentation

A person exploring possible bipolarity, a person already diagnosed, and loved ones do not need the same message.

Company constraints

The work needed to be useful for a company team making practical marketing and adoption decisions.

Method

A mixed-method patient insight program

HopeStage combined lived-experience access with structured marketing thinking, so the work could move from patient voice to decisions the Alcediag team could actually use.

Qualitative interviews

Interviews with people affected by bipolarity and loved ones to understand expectations, fears, vocabulary, and the emotional context around diagnosis.

Survey and community distribution

A questionnaire designed for HopeStage communities and newsletter audiences to quantify attitudes around diagnosis, acceptance, and blood-test perception.

Focus group design

A deeper discussion format to test reactions to value propositions, willingness to pay, and how a test result could affect real life.

Personas and journey mapping

Personas for people living with bipolarity, loved ones, and people experiencing depression who may be looking for clearer answers.

Positioning and messaging

Strategic recommendations to explain myEDIT-B with clarity, empathy, and practical relevance.

Marketing funnel

A path from awareness to interest, consideration, intent, and action, adapted to mental health decision-making.

Clément Baissat with Alcediag's lead researcher
Working with Alcediag's research team to connect scientific constraints with patient language.
Testimonial

Alexandra Prieux

CEO @ Alcediag

"Clément brought a marketing perspective to what we were doing, which is quite unusual when you talk to patients. It is marketing, but it is very specific because it is a patient in front of us, a person who potentially is suffering. Clément helped us understand the need of the patient and how to address it properly and respectfully."

Alexandra Prieux highlighted the value of connecting company constraints with patient reality in a way that remains practical, specific, and respectful.

Alexandra Prieux, CEO of Alcediag
Alexandra Prieux, CEO @ Alcediag
Watch Alexandra's testimony
What changed

The work clarified who Alcediag needed to speak to, and how.

The highest-value output was audience segmentation: identifying the main types of people Alcediag could speak to and how to address each group respectfully.

Clearer personas

Alcediag could distinguish between people questioning their diagnosis, people already living with bipolarity, and loved ones trying to help.

More respectful messaging

The positioning avoided treating people as a generic market and instead reflected the emotional reality of diagnosis and uncertainty.

Decision-ready insight

The project translated lived experience into practical marketing, communication, and adoption recommendations.

Outputs

What HopeStage delivered

For mental health innovators

Patient insight should change the strategy, not just decorate it.

HopeStage helps mental health diagnostics, biotech, digital health, and research teams understand what patients need to trust before they act.